This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Metabolix Investor Investigation - The Briscoe Law Firm And Powers Taylor, LLP Announce Investigation Of Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Metabolix, Inc.





DALLAS, Feb. 27, 2012 /PRNewswire/ -- Former United States Securities and United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor, LLP announce that the firms are investigating legal claims against the officers and Board of Directors of Metabolix, Inc. ("Metabolix") (NASDAQ: MBLX) related to potential securities violations between March 10, 2010 and January 12, 2012 (the "Class Period").

(Logo: http://photos.prnewswire.com/prnh/20111111/DA05320LOGO)

If you are an affected investor and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at patrick@powerstaylor.com, or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com.  There is no cost or fee to you.

"Recent revelations about the company's alleged failure to disclose to the investing public that its joint venture with the Archer Daniels-Midland Company, to sell and market Metabolix's polyhydroxyalkanoate ("PHA") bioplastics product Mirel, was not meeting certain development and commercial benchmarks have prompted the firms to investigate possible breaches of fiduciary duties and other violations of state law by Metabolix's officers and directors.  Based on our investigation, we are prepared to pursue litigation to preserve the company and the value of Metabolix stock for all shareholders, including seeking removal of certain officers and directors and monetary payments," said shareholder rights attorney Willie Briscoe.

In a recently filed federal class action complaint, Metabolix and certain of its officers and directors were charged with violating the Securities Exchange Act of 1934.  Specifically, the complaint alleges that during the Class Period, defendants misrepresented or failed to disclose the following adverse facts: (a) that Metabolix's Telles LLC joint venture project with Archer Daniels-Midland Company ("ADM") would not meet its commercial phase benchmark as early as mid-2010, or even in 2011, which would allow Metabolix to receive royalty payments and payments from services from Telles; and (b) that Metabolix's Mirel product was not a commercially viable product that would offer value to Metabolix.  According to the complaint, on January 12, 2012, Metabolix announced that ADM had given notice of termination of the Telles joint venture project because of uncertainty about projected capital and production costs, combined with the rate of market adoption, which led to projected financial returns for ADM that were too uncertain, the value of Metabolix shares declined significantly.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,136.16 +94.62 0.52%
S&P 500 2,114.19 +9.99 0.47%
NASDAQ 5,065.9740 +33.2230 0.66%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs